Non-small Cell Lung Cancer Metastatic Clinical Trials
0 recruiting
Showing 1–7 of 7 trials
Recruiting
Phase 1Phase 2
A Phase 1b/2 Study of the Safety and Efficacy of the Monoclonal Antibody OM-RCA-01 in Patients With Metastatic Tumors Expressing Fibroblast Growth Factor Receptor 1
Breast Cancer MetastaticRenal Cell Carcinoma MetastaticProstate Cancer Metastatic+2 more
Kidney Cancer Research Bureau58 enrolled5 locationsNCT07292168
Recruiting
Not Applicable
Circulating Tumor DNA Guided Treatment Monitoring in Advanced Lung Cancer
Non-small Cell Lung Cancer Metastatic
Zealand University Hospital350 enrolled5 locationsNCT05889247
Recruiting
Clinical Research Platform Into Molecular Testing, Treatment and Outcome of (Non-)Small Cell Lung Carcinoma Patients
Non-small Cell Lung Cancer MetastaticNon-small Cell Lung Cancer Stage IIMetastatic Non-small Cell Lung Cancer (NSCLC)
AIO-Studien-gGmbH12,400 enrolled1 locationNCT02622581
Recruiting
Phase 2
High-dose Furmonertinib Combined With Bevacizumab and Intrathecal Pemetrexed Chemotherapy in Patients With EGFR-mutated Non-small Cell Lung Cancer and Meningeal Metastasis
Non-small Cell Lung Cancer Metastatic
Sun Yat-sen University30 enrolled1 locationNCT06812871
Recruiting
Phase 2
Befotertinib and Icotinib for NSCLC With Uncommon EGFR Mutations
Non-small Cell Lung Cancer MetastaticEGFR G719XEGFR L861Q+1 more
Sun Yat-sen University23 enrolled1 locationNCT06517953
Recruiting
Phase 1
An Early Stage Study to Evaluate Oba01 for Injection in Patients With DR5 Positive LA/mNSCLC
Non-small Cell Lung Cancer Metastatic
Lu Shun35 enrolled1 locationNCT06083870
Recruiting
Phase 3
Armatinib Alone or in Combination With SRT for Brain Metastases EGFR-mutated Non-small Cell Lung Cancer
Non-small Cell Lung Cancer Metastatic
Shanghai Cancer Hospital, China300 enrolled1 locationNCT05800223